INSIDER · CIK 1778623
Veness Adam M
SVP, General Counsel and Sec. at Dianthus Therapeutics, Inc. /DE/ (DNTH)
↗3 Form 4 rows in the window
Covers original filings from Aug 1, 2026 to Oct 29, 2026. Older trades and amendments are in the SEC history.
$0.00Bought on the market
$2.2MSold on the market
1Companies
Aug 14, 2026Latest filing
| Company | Title | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 14, 202616:30 | Aug 13, 2026 | DNTHDianthus Therapeutics, Inc. /DE/ | SVP, General Counsel and Sec. | M · Exercise | $18.17 | +15,000 | 15,000 | New | $273K | ||
| Aug 11, 202617:08 | Aug 10, 2026from Aug 7, 2026 | DNTHDianthus Therapeutics, Inc. /DE/ | SVP, General Counsel and Sec. | S · Sell10b5-1 | $110.44 | −20,000 | 0 | -100% | −$2.2M | ||
| Aug 11, 202617:08 | Aug 10, 2026from Aug 7, 2026 | DNTHDianthus Therapeutics, Inc. /DE/ | SVP, General Counsel and Sec. | M · Exercise10b5-1 | $17.88 | +20,000 | 16,167 | — | $358K |